| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |